Guided Therapeutics Inc (GTHP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 6 | 32 | 0 | 44 |
| Cost of Goods | 0 | 2 | 16 | 4 | 33 |
| Gross Profit | 0 | 4 | 16 | -4 | 11 |
| Operating Expenses | 655 | 365 | 518 | 623 | 1,549 |
| Operating Income | -655 | -359 | -486 | -623 | -1,505 |
| Interest Expense | 75 | 64 | 72 | 71 | 69 |
| Other Income | 21 | 21 | 172 | 17 | 17 |
| Pre-tax Income | -709 | -402 | -386 | -677 | -1,557 |
| Net Income Continuous | -709 | -402 | -386 | -677 | -1,557 |
| Net Income | $-709 | $-402 | $-386 | $-677 | $-1,557 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.01 | 0.00 | N/A | N/A |
| EBITDA(a) | $-613 | $-304 | $-431 | $-570 | $-1,450 |